Search
for
Sort by
highly targeted anti-androgen that might have minimal systemic effects
a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials